Sunday, 5 October 2025
  
Login

Australia's most trusted
source of pharma news

Sunday, 05 October 2025
News

Six winners snag Oct PBS listings

Posted 2 October 2025 AM

The second month of Spring ushered in six new PBS listings with Novartis scoring victory for two of its treatments.

Lucentis, for the  treatment of proliferative diabetic retinopathy (PDR) without diabetic macular oedema will be available from this month. Health Minister Mark Butler said around 500 patients are expected to benefit from the listing, each saving more than $9000 for a year's treatment.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Sales & Customer Relations (25)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (2)

Devices (1)

Other (15)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.